Information for navigating COVID-19 with testing.
Given the unparalleled threats and uncertainty brought on by COVID-19, sharing information is more important than ever. Here you’ll gain insights, knowledge and strategies to help you navigate the challenges, improve decision-making and take control of your workplace and your life.
The “Say Yes! COVID Test” program is providing millions of rapid antigen tests to four communities experiencing COVID-19 surges this fall
Passing the test: That’s what the NIH and CDC are doing in select communities with a new program that is distributing rapid-antigen COVID-19 tests to consumers for use at home.
People of color are up to 9 times more likely to get COVID-19 and, if they do, they’re more likely to be hospitalized, too.
As head of the classes, school Superintendent Manuel Valenzuela shares challenges of keeping kids learning and safe through COVID-19, as well as some lessons learned through the pandemic.
The work-from-home option simply doesn’t work for all employees. How can organizations with people on-site keep everybody safe from COVID-19? Testing is the answer. This blog provides tools to help employers implement workplace testing programs.
Testing and breakthroughs: The Delta variant of COVID-19 is a new beast to battle, and breakthrough transmission raises questions on testing approaches. This blog covers factors for researchers to consider.
T-cell tests 101: Learn what affects T-cell-based tests, how these diagnostic tools can be used and when immune response tests should be used.
Viral load impacts disease severity, and most COVID-19 testing identifies it, but this data rarely gets reported. This blog explains why and looks at some challenges in sharing viral load test results with clinicians and epidemiologists.
You may not be feeling sick as a dog, but if you’ve been infected with COVID-19, there’s a good chance a dog would sniff it out.
Variants, vaccination and testing: Factor all three into COVID-19 diagnostics, and things get complicated. Variants have the potential to impact the accuracy of some tests, while vaccination raises the possibility of false positives.
Which COVID-19 strains are most worrisome? Can they re-infect people who’ve already recovered from one bout of the virus? Do mutations threaten to derail our testing strategies, treatment protocols and vaccine effectiveness?